Novartis AG (NVS) Q2 2015 Earnings Results

Novartis Beats on EPS, Stock Down 2.27%

Novartis reported earnings that exceeded expectations on EPS, but the stock fell by 2.27% following the report. The decline may reflect investor concerns about the lack of revenue details and overall market conditions. Without updated guidance, investors may remain cautious about the company's future performance.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$1.27	N/A	+5.57%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Neutral

Overall, management expressed a cautious outlook amid market pressures. They reiterated their commitment to advancing their product pipeline.

Management highlighted ongoing challenges in the market.

They emphasized a focus on innovation and pipeline development.

Novartis Beats on EPS, Stock Down 2.27%

Key numbers

Management commentary

Novartis AG

More earnings this week

Novartis Beats on EPS, Stock Down 2.27%

Key numbers

Management commentary